{
  "actions": [
    {
      "acted_at": "2003-02-05",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2003-02-05",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2003-02-05",
      "action_code": "H11100",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2003-02-14",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Commerce, Trade and Consumer Protection.",
      "type": "referral"
    },
    {
      "acted_at": "2003-03-06",
      "action_code": "",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr608-108",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU",
      "subcommittee": "Subcommittee on Courts, Intellectual Property, and the Internet",
      "subcommittee_id": "03"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Innovation, Data, and Commerce",
      "subcommittee_id": "17"
    }
  ],
  "congress": "108",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2003-02-05",
  "number": "608",
  "official_title": "To provide for prices of pharmaceutical products that are fair to the producer and the consumer, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Pharmaceutical Products Price Equity Act",
  "sponsor": {
    "bioguide_id": "O000159",
    "district": "11",
    "name": "Owens, Major R.",
    "state": "NY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2003-02-05",
  "subjects": [
    "Administrative procedure",
    "Administrative remedies",
    "Civil actions and liability",
    "Class actions (Civil procedure)",
    "Commerce",
    "Crime and Law Enforcement",
    "Damages",
    "Drug industry",
    "Economics and Public Finance",
    "Fines (Penalties)",
    "Government Operations and Politics",
    "Health",
    "Injunctions",
    "Law",
    "Legal fees",
    "Prescription pricing",
    "Price discrimination",
    "Price regulation",
    "Punitive damages"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2003-02-05",
    "date": "2006-11-28T17:35:40Z",
    "text": "Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements, to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Pharmaceutical Products Price Equity Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To provide for prices of pharmaceutical products that are fair to the producer and the consumer, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Pharmaceutical Products Price Equity Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-15T21:48:59Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/108/hr/BILLSTATUS-108hr608.xml"
}